miRNA as a Modulator of Immunotherapy and Immune Response in Melanoma
Immune checkpoint inhibitors are a promising therapy for the treatment of cancers, including melanoma, that improved benefit clinical outcomes. However, a subset of melanoma patients do not respond or acquire resistance to immunotherapy, which limits their clinical applicability. Recent studies have...
| Published in: | Biomolecules |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-11-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-273X/11/11/1648 |